https://www.immunewatch.com https://www.immunewatch.com/about-us https://www.immunewatch.com/careers https://www.immunewatch.com/contact https://www.immunewatch.com/news https://www.immunewatch.com/privacy-and-cookie-policy https://www.immunewatch.com/use-cases https://www.immunewatch.com/credits-academia https://www.immunewatch.com/immunoinformatics-service https://www.immunewatch.com/news/4-lessons-curacell-til-therapy-cold-tumors-tcr-sequencing https://www.immunewatch.com/news/ai-in-health-2025-tcr-repertoire-analysis https://www.immunewatch.com/news/applications-of-tcr-epitope-prediction-models-webinar https://www.immunewatch.com/news/beyond-the-sequence-how-obsidian-therapeutics-overcame-4-hurdles-in-implementing-tcr-repertoire-sequencing https://www.immunewatch.com/news/can-tcr-epitope-models-unlock-deeper-insights-into-t-cell-responses https://www.immunewatch.com/news/computational-immunology-airr-seq-diagnostics-review https://www.immunewatch.com/news/contextualising-t-cell-receptor-repertoires-from-chronic-lymphocytic-leukemia-patients-with-immunewatch-detect https://www.immunewatch.com/news/events-webinar-tcr-antigen-specificity-annotation-jan-2026 https://www.immunewatch.com/news/from-postdoc-to-biotech-ceo-conversation-sander-wuyts-immunewatch https://www.immunewatch.com/news/gsk-vaccines-2022-award https://www.immunewatch.com/news/immunewatch-and-milaboratories-partner-to-bring-tcr-epitope-annotations-to-platforma-bio https://www.immunewatch.com/news/immunewatch-awarded-prestigious-seal-of-excellence-by-european-commission https://www.immunewatch.com/news/immunewatch-co-founder-kris-laukens-receives-scientific-award-from-the-astrazeneca-foundation https://www.immunewatch.com/news/immunewatch-detect-assists-in-uncovering-the-role-of-cmv-in-t-cell-leukemia https://www.immunewatch.com/news/immunewatch-detect-demo-at-airr-community-meeting-vii https://www.immunewatch.com/news/immunewatch-detect-finds-the-specificity-of-t-cell-receptor-clusters-in-a-new-science-advances-paper https://www.immunewatch.com/news/immunewatch-detect-mcp-launch https://www.immunewatch.com/news/immunewatch-detect-model-leads-the-field-in-immrep23-tcr-epitope-prediction-challenge https://www.immunewatch.com/news/immunewatch-detect-reveals-a-potential-viral-trigger-for-lung-transplant-failure https://www.immunewatch.com/news/immunewatch-discovernet-msca-doctoral-network https://www.immunewatch.com/news/immunewatch-featured-on-qiagen-website https://www.immunewatch.com/news/immunewatch-invited-to-present-at-the-state-of-the-union-of-flanders-bio-and-vib-during-the-young-company-pitches https://www.immunewatch.com/news/immunewatch-is-attending-sitc-2024 https://www.immunewatch.com/news/immunewatch-is-named-as-a-deep-tech-pioneer-by-hello-tomorrow https://www.immunewatch.com/news/immunewatch-partners-with-single-cell-discoveries-to-bring-tcr-epitope-annotations-to-single-cell-services https://www.immunewatch.com/news/immunewatch-quantoom-biosciences-univercells-and-uantwerp-join-forces-to-explore-new-in-vitro-and-in-silico-assays-that-predict-t-cell-responses-in-vaccines https://www.immunewatch.com/news/immunewatch-receives-antwerp-innovation-grant-to-accelerate-vaccine-development-with-ai https://www.immunewatch.com/news/immunewatch-receives-horizon-europe-funding-in-a-new-innovative-european-partnership-to-tackle-hurdles-in-malaria-vaccine-development https://www.immunewatch.com/news/immunewatch-releases-white-paper-evaluating-the-effect-of-mutations-gathered-in-the-sars-cov-2-omicron-variant-on-t-cell-immunity https://www.immunewatch.com/news/immunewatch-secures-a-vlaio-grant-to-tailor-their-technology-to-vaccine-developers https://www.immunewatch.com/news/immunewatch-selected-for-innovative-ideas-pitch https://www.immunewatch.com/news/immunewatch-signs-licence-agreement-with-uantwerp-and-uza-and-officially-becomes-a-university-spin-off-company https://www.immunewatch.com/news/immunewatch-singleron-single-cell-epitope-annotation https://www.immunewatch.com/news/immunewatch-swiss-biotech-day-2026 https://www.immunewatch.com/news/immunewatch-tcr-epitope-database-update-q3-2025 https://www.immunewatch.com/news/immunewatch-validates-their-expertise-in-tcr-specificity-prediction-in-an-independent-machine-learning-competition https://www.immunewatch.com/news/immunewatch-will-be-attending-the-world-vaccine-congress-europe-in-amsterdam https://www.immunewatch.com/news/immunewatch-wins-one-to-watch-award-2025 https://www.immunewatch.com/news/increase-the-clinical-value-of-your-tcr-sequencing-data https://www.immunewatch.com/news/interpretable-deep-learning-in-immunology https://www.immunewatch.com/news/introducing-a-paradigm-shift-in-tcr-based-diagnostics https://www.immunewatch.com/news/introducing-immunewatch-detect-a-new-bioinformatics-tool-for-finding-the-epitope-specificity-of-your-t-cell-receptors https://www.immunewatch.com/news/introducing-the-launch-of-our-new-podcast-series-the-repertoire-room https://www.immunewatch.com/news/invited-keynote-speaker-the-future-of-ai-for-health https://www.immunewatch.com/news/irepertoire-webinar-decoding-tcr-specificity-using-predictive-ml-models https://www.immunewatch.com/news/keynote-next-generation-vaccines-and-immunotherapy https://www.immunewatch.com/news/launching-the-immunewatch-detect-early-access-program https://www.immunewatch.com/news/meet-us-at-wvc-2025-or-aacr-annual-meeting-2025 https://www.immunewatch.com/news/new-academic-paper-benchmarking-solutions-to-the-t-cell-receptor-epitope-prediction-problem https://www.immunewatch.com/news/new-academic-paper-discovering-the-link-between-t-cell-receptor-diversity-and-herpes-zoster-risk https://www.immunewatch.com/news/new-academic-paper-tcrblosum-for-advancing-tcr-repertoire-analysis https://www.immunewatch.com/news/new-academic-paper-using-tcr-sequencing-and-ai-to-shed-light-on-the-intricate-dynamics-of-our-immune-system-during-sars-cov-2-infection https://www.immunewatch.com/news/new-feature-annotate-the-hla-binding-preference-of-your-tcrs-with-immunewatch-detect https://www.immunewatch.com/news/new-repertoire-room-podcast-episode-arman-aksoy-obsidian-therapeutics-on-the-hurdles-and-advantages-of-implementing-tcr-seq-in-biotech https://www.immunewatch.com/news/new-repertoire-room-podcast-episode-lucas-arruda-curacell-til-therapy-cold-tumors https://www.immunewatch.com/news/new-repertoire-room-podcast-episode-samra-turajlic-on-multiomics-kidney-cancer-and-the-power-of-tcr-seq https://www.immunewatch.com/news/new-review-on-single-cell-t-cell-receptor-repertoire-analysis https://www.immunewatch.com/news/new-white-paper-on-tcr-sequencing-for-cancer-vaccine-developers https://www.immunewatch.com/news/our-ceo-is-an-invited-speaker-at-vib-conference-next-generation-mrna-vaccines-against-complex-pathogens https://www.immunewatch.com/news/pieter-meysman-the-scientist-t-cell-nomenclature https://www.immunewatch.com/news/podcast-the-repertoire-room---episode-2-featuring-stanislav-poslavsky-milaboratories https://www.immunewatch.com/news/predicting-epitope-specificity-for-an-entire-t-cell-atlas https://www.immunewatch.com/news/press-release-pre-existing-immune-cells-can-predict-early-response-to-hepatitis-b-vaccine https://www.immunewatch.com/news/release-of-our-reverse-vaccinology-white-paper https://www.immunewatch.com/news/roche-diagnostics-awards-research-grant-to-uantwerp-team-behind-immunewatch https://www.immunewatch.com/news/sander-wuyts-speaker-asa-ssgg-webinar-statistical-genomics-2025 https://www.immunewatch.com/news/selected-to-pitch-at-knowledge-for-growth https://www.immunewatch.com/news/t-cell-monitoring-in-cancer-vaccine-research https://www.immunewatch.com/news/tcr-sequencing-as-a-diagnostic-tool-our-cto-pieter-meysman-co-authors-perspective-on-next-generation-immune-diagnostics https://www.immunewatch.com/news/til-product-characterisation-immunewatch-detect https://www.immunewatch.com/news/using-immunewatch-detect-within-platforma-to-annnotate-epitope-and-hla-specificity-of-tcrs https://www.immunewatch.com/news/watch-out-for-negative-data-bias-in-machine-learning https://www.immunewatch.com/news/we-are-attending-nextgen-biomed https://www.immunewatch.com/news/we-are-attending-the-festival-of-genomics-and-biodata-london https://www.immunewatch.com/news/webinar-annotate-the-specificity-of-your-tcrs-on-platforma https://www.immunewatch.com/news/webinar-annotating-antigen-specificity-of-t-cell-receptor-repertoires-in-clinical-oncology https://www.immunewatch.com/news/webinar-annotating-antigen-specificity-of-tcr-repertoires-in-clinical-oncology https://www.immunewatch.com/news/webinar-annotating-the-antigen-specificity-of-a-tcr-repertoire https://www.immunewatch.com/news/webinar-applications-of-tcr-epitope-prediction-models https://www.immunewatch.com/news/webinar-can-you-actually-trust-computational-tcr-epitope-annotations https://www.immunewatch.com/news/webinar-how-can-i-find-the-epitope-specificity-of-my-t-cell-receptors https://www.immunewatch.com/news/webinar-tcr-repertoire-analysis-for-t-cell-based-therapies https://www.immunewatch.com/news/webinar-tcr-sequencing-clinical-insights https://www.immunewatch.com/news/webinar-tcr-vdj-sequencing-valuable-insights https://www.immunewatch.com/news/webinar-what-are-your-t-cells-really-doing-a-guide-to-single-cell-tcr-sequencing-analysis https://www.immunewatch.com/news/webinar-with-our-cto-pieter-meysman https://www.immunewatch.com/news/weve-listened-new-features-added-to-immunewatch-detect https://www.immunewatch.com/news/what-are-your-t-cells-really-doing-a-journey-through-tcr-single-cell-data-and-epitope-annotation https://www.immunewatch.com/news/white-paper-how-reliable-are-antigen-specificity-annotations-for-t-cell-receptors https://www.immunewatch.com/news/white-paper-tcr-antigen-specificity-annotation-reliability-detect https://www.immunewatch.com/news/z-healthcare-features-immunewatch https://www.immunewatch.com/news/z-innovation-features-immunewatch